Optiscan CEO and Managing Director Dr. Camile Farah has been featured in Stockhead TV regarding key developments in Optiscan's progress towards revolutionizing cancer treatment and enhancing surgical precision.

In the interview, Camile shares insights on:

• Our ethical clearance to conduct a human study on cancer margins in breast cancer surgeries.
• How our InVue™ precision surgery imaging platform works.
• The details of our study, which aims to collect crucial imaging data from the surgical cavity post-tumour removal.

See the full interview here.